Literature DB >> 19173192

[The role of interleukin-18 in the pathogenesis of bronchial asthma and other allergic diseases and in activation of basophils and mastocytes].

Marek Kamiński1, Karolina Kłoda, Andrzej Pawlik.   

Abstract

Interleukin-18 is a proinflammatory cytokine produced by a wide range of cells and is involved in the pathogenesis of several inflammatory diseases such as atopic asthma. It was recently demonstrated that IL-18 acts on T cells to induce airway inflammation and airway hyperresponsiveness. These observations strongly indicate that IL-18 stimulates Th1 cells to produce cytokines and chemokines responsible for the airway infiltration and inflammatory responsiveness. Moreover IL-18 activates mast cells and basophils playing the important role in atopy. Atopic asthma is characterized by eosinophilic airway inflammation, remodeling, mucus hypersecretion and high serum levels of IgE. Most current data suggest that asthma drives development of a Th2 lymphocyte-predominant immune response, which is associated with atopy and IgE mediated inflammation via pathways involving the production of proinflammatory cytokines such as IL-18. Here we discuss the functional role of IL-18 in activation of mast cells and basophils and pathogenesis of allergic diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19173192

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN: 0867-7077


  2 in total

Review 1.  State-of-the-art review about basophil research in immunology and allergy: is the time right to treat these cells with the respect they deserve?

Authors:  Salvatore Chirumbolo
Journal:  Blood Transfus       Date:  2011-12-21       Impact factor: 3.443

2.  Sublingual Immunotherapy for Asthma: Affects T-Cells but Does not Impact Basophil Activation.

Authors:  Olga Ciepiela; Anna Zawadzka-Krajewska; Iwona Kotuła; Frans van Overveld; Marek Kulus; Urszula Demkow
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-03-01       Impact factor: 1.349

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.